July 24, 2025 · Form 4 insider transaction
Mesa Nilda bought 650 shares of United Therapeutics Corporation at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.; Annual non-employee director award.; Not applicable as restricted stock units do not have an expiration date.